Dr. Ian Gemmill
Kingston, Frontenac and Lennox & Addington Public Health
Dr. Ian Gemmill has been the Medical Officer of Health for Kingston, Frontenac and Lennox & Addington Public Health since 1997. Previously, he was the Associate Medical Officer of Health for the Ottawa-Carleton Health Department from 1981 to 1997 and was Director of the Sexual Health Clinic in Ottawa. He is a graduate of the Faculty of Medicine at Queen's University, a fellow of the Royal College of Physicians and Surgeons of Canada in Public Health & Preventive Medicine, an Honorary Life Member of the Canadian Public Health Association (CPHA), and a Fellow of the College of Family Physicians of Canada.
Dr. Gemmill has 31 years of experience in public health in Ontario and has a strong interest in communicable diseases, immunisation, sexually transmitted diseases, sexual health and tobacco use control. He is currently chair of Ontario's & rovincial Infectious Diseases Advisory Committee on Immunisation, he sits on the National Advisory Committee on Immunisation (NACI) (1996-2003 and 2013 to the present as a full member, 2011 to 2013 as a liaison member for the CPHA), and serves on NACI's working group on influenza vaccine.
Dr Gemmill has served on a number of other national and provincial committees on communicable diseases and immunisation. He is the former chair of the Canadian Coalition for Immunisation Awareness and Promotion and he served as co-chair of the Pandemic Vaccine Working Group for the Public Health Agency of Canada (2008 to 2010). He was a member of the Ontario Provincial Advisory Committee on Communicable Diseases (1996 to 2004), the Board of the National Cancer Institute of Canada (2007-2009) and the Board of Directors of the Canadian Public Health Association (several terms). Dr Gemmill is an Associate Professor in the Departments of Community Health & Epidemiology and of Family Medicine at Queen's University, and is currently director of the Public Health & Medicine Residency Programme at Queen's.
Dr. Caroline Quach-Thanh
Caroline Quach-Thanh is an Associate Professor of Pediatrics and an associate member of the Department of Epidemiology and Biostatistics at McGill University. She is the co-director of the McGill University Health Center Vaccine Study Center and works as a pediatric infectious diseases consultant and a medical microbiologist at The Montreal Children's Hospital. She also has a cross-appointment at the Quebec Institute of Public Health. Caroline Quach graduated from the Université de Montréal Medical School, did her pediatric training at Sainte-Justine Hospital, and her post-graduate Infectious Diseases and Medical Microbiology training at McGill University where she also obtained a Masters of Sciences in Epidemiology. Her research interests are focused on the prevention of infections – both healthcare-associated infections and vaccine-preventable diseases. She currently also serves on the Quebec Immunization Committee (CIQ), the Quebec Nosocomial Infection Committee (CINQ), and chairs the Quebec Daycare Infection Prevention Committee (CPISGEQ).
Dr. Natalie Dayneka
Childen's Hospital of Eastern Ontario (CHEO)
Natalie Dayneka is a clinical specialist with the Pharmacy Department of the tertiary care pediatric teaching hospital, Children's Hospital of Eastern Ontario (CHEO). As a pediatric pharmacist, Natalie has played an active role developing pediatric guidelines for Infectious Diseases, including Immunizations. She is a co-author of the online 2015 CHEO Antimicrobial Guidelines for Children which have been offered externally as a mobile application (APP) for pediatric practitioners across Canada.
Natalie has consulted on other federal committees and was a member of the Pharmacology and Therapeutics Committee for the First Nations and Inuit Health Programs Directorate. She also served on the Canadian Paediatric Society's Drug Therapy and Hazardous Substances Committee. More recently, Natalie served on the Ontario Quality Based Procedure Tonsillectomy Clinical Expert Advisory Group.
Natalie has been very active with the Canadian Society of Hospital Pharmacists (CSHP) and was awarded the title of Fellow. She is currently Chair of the Canadian HIV/AIDS Pharmacists Network (CHAP). Natalie has presented lectures and posters at regional, national and international meetings.
Public Health Ontario
Dr. Shelley Deeks is the Medical Director of Immunization and Vaccine Preventable Diseases at Public Health Ontario and an Associate Professor at the Dalla Lana School of Public Health, University of Toronto. She is a member of Canada's National Advisory Committee on Immunization, Scientific Lead of Ontario's Provincial Infectious Diseases Advisory Committee on Immunization and Past Chair of the World Health Organization's Immunization Practices Advisory Committee. Dr. Deeks holds Fellowships in Public Health in both Canada and Australia.
Dr. Bonnie Henry
Centre for Disease Control and University of British Columbia
Vancouver, British Colombia
Bonnie Henry is currently the Director of Public Health Emergency Management with the British Columbia Centre for Disease Control and is Medical Director for the provincial Emerging and Vector-borne Diseases program as well as a provincial program for surveillance and control of healthcare associated infections; a position she started in February of 2005. Previously she was Associate Medical Officer of Health for Toronto Public Health, where she was responsible for the Emergency Services Unit and the Communicable Disease Liaison Unit. She is a specialist in Community Medicine and is Board Certified in Preventive Medicine in the US. She graduated from Dalhousie Medical School and completed a Masters in Public Health in San Diego, residency training in preventive medicine at University of California, San Diego and in community medicine at University of Toronto. More recently, Dr. Henry worked with the WHO/UNICEF Polio eradication program in Pakistan in 2000 and with the World Health Organisation to control the Ebola outbreak in Uganda in 2001. She joined Toronto Public Health in September 2001 and in 2003 was one of the leads in the response to the SARS outbreak in Toronto. She was on the executive of the Ontario SARS Scientific Advisory Committee and is an assistant professor at the University of British Columbia, Faculty of Medicine. She is currently the Chair of Immunization Canada where she has led the development of programs for the promotion of immunization throughout life.
Ms. Sheila Marchant-Short
Charlottetown Public Health Nursing, Health PEI
Sheila is a Public Health Nurse who is currently with Health PEI as Clinical Leader in Charlottetown Public Health Nursing. She completed a BScN from The University of Western Ontario, a MScN from The University of British Columbia and she is currently completing a PhD from the Faculty of Medicine, Memorial University of Newfoundland. She is originally from Maple Grove, Ontario, but has lived and worked across Canada, including Ontario, British Columbia, Newfoundland and Labrador and currently Prince Edward Island. She has spent the majority of her career in public health in a variety of roles including: generalist Public Health Nurse in Western NL, Public Health Nurse consultant at the Epidemiology and Disease Control Centre in Victoria, BC; Nurse Consultant for Immunization Programs and Communicable Disease Control, BC Ministry of Health; Program Manager of Communicable Disease Control and Immunization Programs, North Bay Parry Sound District Health Unit, Ontario; Regional Manager of Communicable Disease Control, Sexual Health Programs and Immunization Programs, Eastern Health, NL.
Sheila has been involved in communicable disease prevention efforts and immunization promotion locally, provincially and nationally. She has been a keynote speaker on topics such as immunization decision-making, influenza, pandemic planning and the role of nurses in communicable disease control and immunization. She has authored chapters on Communicable Disease Control in Community Health Nursing: A Canadian Perspective. She has conducted research on parental immunization decision-making, HIV and Blood borne pathogen transmission and the effect of adverse events on health care providers.
Dr. Marina Salvadori
Children's Hospital of Western Ontario
Marina Salvadori graduated from medicine at Queen's University in 1991.
She did her residency training in pediatrics at the University of Manitoba, Winnipeg, then trained in Infectious Diseases at The Hospital For Sick Children in Toronto. She was working there in May 2000, and joined a team of pediatricians who responded to the call for help from Walkerton. She spent the summer of 2000 working in Walkerton, then moved to London in October 2000. She is currently a pediatric infectious diseases consultant at London Health Sciences Center-Children's Hospital, and an Associate Professor at the Schulich school of medicine and dentistry at the University of Western Ontario, in London, Ontario. She is part of the team that conducted the Walkerton Health Study to provide care and monitor health problems of the people of Walkerton. She is also very interested in immunizations and immunization advocacy and regularly does teaching and workshops about immunizations. She has represented the Canadian Pediatric Society as a liaison member to NACI.
Dr. Nadine Sicard
Ministry of Health and Social Services
Nadine Sicard studied medicine and Public Health at Sherbrooke and Montréal universities. Since 2011, she has been a medical advisor in the Public Health protection team of Quebec's Ministry of Health and Social Services and contributes, particularly, to the immunization and hospital acquired infections teams. She held the position of Associate Medical Officer of Health at Ottawa Public Health from 2008 to 2011, mostly in the areas of communicable disease prevention and control, emergency preparedness and response and management of the vaccine preventable diseases programs. Prior to working in Ottawa, Dr. Sicard worked in the areas of policy development, quality assurance and communicable disease control in Montreal and Abitibi-Témiscamingue. She's been involved in the management of public health outbreaks including pandemic influenza. She has contributed to several provincial and national advisory committees, such as NACI, as the liaison member for the Canadian Public Health Association from 2008 to 2011. Dr Sicard has held adjunct Faculty appointments at l'Université de Montréal and Queen's University. She has been the Chair of the Influenza Working Group of NACI since 2010, and in this role has coordinated the development of several NACI statements related to influenza, such as the annual seasonal influenza statements and newly authorized influenza vaccines.
Dr. Wendy Vaudry
University of Alberta
Wendy Vaudry is Professor of Pediatrics at the University of Alberta and Director of Infectious Diseases at the Stollery Children's Hospital in Edmonton. Her research interests include the epidemiology of vaccine preventable diseases and vaccine adverse events; she is the current national co-PI of IMPACT (the Canadian Pediatric Society and Health Canada's Immunization monitoring program, active). Other research interests include congenital CMV infection and transplant infectious diseases. She is a graduate of Medical School at McGill University and trained in Pediatrics at the Montreal Children's Hospital, Infectious Diseases at the University of Alberta and Transplant Infectious Diseases at the University of Washington.
Dr. Donald Vinh
McGill University Health Centre Research Institute
Dr. Vinh obtained his medical degree in 2001 from McGill University. He then completed a residency in Internal medicine at McGill University (Jewish General Hospital), followed by a combined fellowship in clinical Infectious Diseases at the University of Manitoba and in Medical Microbiology at McGill. He subsequently completed a post-doctoral translational research fellowship at the National Institutes of Health (NIH) to understand inborn errors of immunity that render humans susceptible to infections, particularly fungal diseases. This research, in the laboratory of Dr. Steve Holland, was supported by a CIHR post-doctoral fellowship award as well as a NIH Visiting Fellow award. This work focused on understanding chronic granulomatous disease, autosomal-dominant hyper-IgE (Job's) syndrome, and defects in the interleukin (IL)-12/interferon (IFN)-gamma axis. It culminated in the discovery of a new genetic immunodeficiency, MonoMac syndrome, due to mutations in GATA2. His work earned him the Canadian Foundation for Infectious Diseases Excellence in Infectious Disease Research Award in 2010 and the 2013-2014 NIAID Merit Group Award as a member of the GATA2 Discovery Group (for outstanding clinical and basic research leading to the discovery and characterization of GATA2 Deficiency).
Dr. Vinh is Assistant Professor and FRQS (Fondation de recherche du Québec – Santé) Clinician-Scientist in the Division of Infectious Diseases and the Division of Allergy & Clinical Immunology, in the Department of Medicine at the MUHC. He is also Assistant Professor in the Department of Medical Microbiology and Affiliate in the Department of Human Genetics. He has established the Infectious Disease Susceptibility Program at the MUHC, a translational research program on genetic immune deficiencies and immunocompromised hosts.
Dr. Richard Warrington
University of Manitoba
Richard Warrington received his Medical degree from the Royal London Hospital, London, England in 1968, and moved to St John's, Newfoundland in 1969 to help found the new Medical School at Memorial University. He received his PhD in Immunology from Memorial University, in 1973. He trained in Allergy & Clinical Immunology at the University of Manitoba until 1976, when he joined the Section of Allergy & Clinical Immunology in the Department of Medicine., which he has headed since 1982. From 1983 to 1996, Dr. Warrington directed the Rheumatic Disease Unit Research Laboratory at the University of Manitoba. His research has been on cytokines and autoantibodies and drug hypersensitivity. He is currently studying the effects of anti-cytokines antibodies in intravenous gammaglobulin.
Richard Warrington is Professor of Medicine & Immunology at the University of Manitoba, A Fellow of the Royal College of Physicians & Surgeons of Canada, past Chief Examiner for the Royal College of Physicians and Surgeons of Canada, a Fellow of the American Academy of Allergy, Asthma & Immunology, President of the Canadian Society of Allergy & Clinical Immunology.
Mr. Robert Lerch
Association of Medical Microbiology and Infectious Disease Canada
Dr. Anne Pham-Huy
Canadian Association for Immunization Research and Evaluation
Dr. Jason Brophy
Canadian Immunization Committee
Ms. Elaine Sartison
Canadian Public Health Association
Dr. Catherine Mah
Canadian Paediatric Society
Dr. Dorothy Moore
Center for Disease Control and Prevention
Dr. Amanda Cohn
Atlanta, Georgia, USA
College of Family Physicians of Canada
Dr. Julie Emili
Council of Chief Medical Officers of Health
Dr. Martin Lavoie
Society of Obstetrics and Gyneacologists
Dr. Jennifer Blake
Biologics and Genetic Therapies Directorate
Dr. Gina Coleman
Centre for Immunization and Respiratory Infectious Diseases (CIRID)
Immunization Programs and Pandemic Preparedness Division
Ms. Gina Charos
Public Health Agency of Canada
Centre for Immunization and Respiratory Infectious Diseases (CIRID)
Surveillance and Epidemiology Division
Ms. Jennifer Pennock
Public Health Agency of Canada
Directorate of Force Health Protection
Dr. (LCdr/Capc) Kirsten Barnes
National Defence and the Canadian Armed Forces
First Nations and Inuit Health Branch
Dr. Tom Wong
Marketed Health Products Directorate
Dr. Jim Gallivan